ピロキシカム
ピロキシカムはオキシカム系の非ステロイド性抗炎症薬(NSAID)です。標準的なNSAIDの特性(抗炎症、鎮痛、解熱)を持っていますが、獣医学における主な用途は、犬の膀胱の**移行上皮癌(TCC)**や、扁平上皮癌、乳腺腺癌などの他の腫瘍の**補助治療**です。 > **臨床のポイント:** ピロキシカムは、新しいCOX-2選択的NSAIDと比較して、犬や猫における治療域が非常に狭いです。胃腸潰瘍のリスクが高いため、現在では変形性関節症の痛みの治療に単独で使用されることはまれです。 血管新生を抑制し免疫系を調節することで肉瘤の再発を防ぐため、シクロホスファミドなどの薬剤とともに**メトロノミック(低用量・持続的)化学療法**プロトコルで使用されることが増えています。
作用機序: Like other NSAIDs, piroxicam non-selectively inhibits **cyclooxygenase (COX)** enzymes, thereby blocking the conversion of arachidonic acid to **prostaglandins** and thromboxanes. This reduces inflammation and pain. Its **anti-tumor effects** are not fully understood but are believed to be indirect. Mechanisms include: * **Inhibition of COX-2** expressed by tumor cells (especially TCC) * **Anti-angiogenesis** (preventing new blood vessel formation to the tumor) * **Immune system modulation** * Inhibition of superoxide formation
動物種別の用量
- Adjunctive therapy of transitional cell carcinomas · 0.3 mg/kg PO q24-72h · PO · q24-72h · Gastric protectants may be useful. Use with caution in pre-existing renal disease.
- Adjunctive therapy of transitional cell carcinomas/neoplastic diseases · 0.3 mg/kg PO every 24-48 hours · PO · q24-48h
- Cancer pain · 0.3 mg/kg PO q24-48h or 1 mg (total dose) per cat PO q24h · PO · q24-48h · Maximum of 7 days
- Antiinflammatory/analgesic · 1 mg per cat (total dose) PO once daily · PO · q24h · Maximum of 7 days
- Idiopathic chronic rhinosinusitis · 0.3 mg/kg PO once daily or every other day · PO · q24-48h
- All uses (e.g., various neoplasms) · 0.3 mg/kg · PO · q24-96h · Long-term · Start at least frequent administration and slowly increase if no side effects observed.
- Mucocutaneous squamous cell carcinoma · 80 mg (total dose) PO once daily · PO · q24h · Dose was eventually reduced to every other day or every third day due to colic signs.
- Squamous cell carcinoma of the third eyelid after surgical excision · 80 mg (total dose) PO once daily · PO · q24h
- Fracture associated limb swelling (Rabbits) · 0.1-0.2 mg/kg PO q8h · PO · q8h · 3 weeks
投与経路
禁忌
- Hypersensitivity to piroxicam, aspirin, or other NSAIDs
- Active or history of gastrointestinal ulcer disease
- Bleeding disorders
- Gastric ulceration
- Renal disease
- Concurrent use of corticosteroids
- Concurrent use of other NSAIDs
- Dehydration (relative contraindication due to renal risk)
有害事象
- Gastrointestinal ulceration and bleeding (melena, hematemesis)
- Vomiting, anorexia, and diarrhea
- Renal papillary necrosis
- Peritonitis (secondary to GI perforation)
- Decreased hematocrit (anecdotal in cats)
- Peripheral edema
- Elevated liver enzymes
- Gastrointestinal toxicity
- Gastric ulceration
- Ulcerative skin lesions (reported in cats)
- Potential precipitation of cardiac failure (known in humans, unknown risk in animals)
薬物相互作用
- Aminoglycosides (gentamicin, amikacin) · Increased risk for nephrotoxicity
- Anticoagulants (heparin, LMWH, warfarin) · Increased risk for bleeding
- Aspirin · Decreased piroxicam plasma levels and increased likelihood of GI adverse effects (blood loss); do not use concurrently
- Bisphosphonates (alendronate) · May increase risk for GI ulceration
- Cisplatin · May potentiate the renal toxicity of cisplatin
- Corticosteroids · Significantly increased risk for GI adverse effects and ulceration · major
- Furosemide · May reduce the saluretic and diuretic effects of furosemide
- Highly protein-bound drugs (phenytoin, valproic acid, sulfonamides) · Piroxicam is 99% protein-bound and may displace other drugs, increasing their serum levels and duration of action
- Methotrexate · Serious toxicity has occurred when used concomitantly; use with extreme caution
- Other NSAIDs · Increased risk of severe gastric ulceration and GI toxicity · major
- Diuretics · Increased risk of nephrotoxicity and renal papillary necrosis · moderate
- Aminoglycosides · Increased risk of nephrotoxicity · moderate
モニタリング
- Adverse Effects (particularly GI bleeding: melena, hematemesis, pale mucous membranes)
- Liver function tests (occasionally with chronic use)
- Renal function tests (occasionally with chronic use)
- Renal function (BUN, Creatinine, SDMA, Urinalysis)
- Liver enzymes
- Clinical signs of GI ulceration (vomiting, melena, anorexia)
- Hydration status
- Skin integrity (especially in cats)
過量投与
Overdosage can lead to severe **gastrointestinal (ulceration, perforation)** and **renal (papillary necrosis, failure)** effects. Dogs may be more sensitive to the ulcerative effects than humans. **Treatment:** * Decontamination with emetics and/or activated charcoal if recent. * Gastrointestinal protectants (e.g., misoprostol, omeprazole, sucralfate) are strongly warranted. * Fluid diuresis should be considered to protect renal function. * Monitor carefully and provide supportive care.
VetSheet の薬剤リファレンスは、獣医療従事者向けの臨床意思決定支援を目的としており、専門的判断やメーカーの最新添付文書に代わるものではありません。